
|

| |
Track this Pro and follow
their portfolio moves with tickerspy™ alerts |
 |
|
 | BB Biotech |
| |
Performance |
|
|
|
Similar Pro Portfolios |
|
|
|
Community |
|
| |
Today:
Week:
1-month:
All-time:
|
-0.8%
-2.8%
-0.1%
+43.0%
|
vs S&P 500:
vs S&P 500:
vs S&P 500:
vs S&P 500:
|
-0.1%
-3.1%
-5.2%
+22.9%
|
Data since: Jan-1-2008 Current Portfolio: Q1 2013
|
|
|
|
|
|
|
|
|
Share this Pro on Facebook
Share this Pro on Twitter
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
| |
|
| |

 |
Click
a column to sort | Scroll over columns for more information |
|
|
| ALXN |
$100.57 |
-2.10 |
-2.05% |
1,131,564 |
71% |
$19.6B |
- |
23% |
-16% |
+5.2% |
$66.1M | 717.4K shares - increase of 267.4K shares
No Alerts/News
|
|
|
| ARIA |
$18.43 |
+0.90 |
+5.13% |
8,155,568 |
277% |
$3.4B |
- |
22% |
-27% |
+0.7% |
$52.2M | 2.9M shares - increase of 300.0K shares
2 Alerts (0 News) - View
|
|
|
| BMRN |
$65.55 |
+0.55 |
+0.85% |
2,177,889 |
167% |
$9.1B |
- |
91% |
-8% |
+6.4% |
$26.0M | 417.3K shares - decrease of 316.5K shares
No Alerts/News
|
|
|
| CELG |
$123.44 |
-0.06 |
-0.05% |
4,199,827 |
126% |
$51.6B |
- |
111% |
-6% |
+5.5% |
$263.1M | 2.3M shares - decrease of 400.0K shares
No Alerts/News
|
|
|
| ECYT |
$13.79 |
-0.44 |
-3.09% |
271,131 |
96% |
$496.0M |
- |
129% |
-10% |
+11.4% |
$29.1M | 2.3M shares - increase of 276.0K shares
No Alerts/News
|
|
|
| GILD |
$55.93 |
-0.54 |
-0.96% |
12,767,258 |
96% |
$85.2B |
- |
132% |
-2% |
+16.6% |
$191.8M | 3.9M shares - decrease of 100.0K shares
2 Alerts (0 News) - View
|
|
|
| HALO |
$7.17 |
-0.42 |
-5.53% |
1,247,909 |
92% |
$811.2M |
- |
86% |
-28% |
+33.5% |
$32.6M | 5.6M shares - increase of 70.0K shares
No Alerts/News
|
|
|
| IMGN |
$17.03 |
-0.17 |
-0.99% |
835,044 |
98% |
$1.4B |
- |
57% |
-6% |
+9.6% |
$55.1M | 3.4M shares - decrease of 123.5K shares
1 Alert (0 News) - View
|
|
|
| INCY |
$22.32 |
+0.06 |
+0.27% |
1,235,415 |
118% |
$3.0B |
- |
45% |
-15% |
-3.0% |
$124.4M | 5.3M shares - increase of 190.3K shares
No Alerts/News
|
|
|
| ISIS |
$20.39 |
-0.42 |
-2.02% |
1,415,123 |
79% |
$2.0B |
- |
170% |
-11% |
+19.8% |
$130.3M | 7.7M shares - decrease of 349.0K shares
No Alerts/News
|
|
|
| MDCO |
$32.53 |
-1.18 |
-3.50% |
3,550,393 |
382% |
$1.8B |
- |
62% |
-13% |
-1.5% |
$33.0M | 987.7K shares - decrease of 590.8K shares
1 Alert (0 News) - View
|
|
|
| MDVN |
$48.54 |
+0.03 |
+0.06% |
1,372,131 |
133% |
$3.6B |
- |
23% |
-18% |
+4.0% |
$58.4M | 1.2M shares - increase of 288.1K shares
No Alerts/News
|
|
|
| ONXX |
$93.03 |
+0.12 |
+0.13% |
1,259,998 |
111% |
$6.7B |
- |
125% |
-8% |
+4.3% |
$48.6M | 546.5K shares - No Change
No Alerts/News
|
|
|
| THRX |
$36.21 |
-1.31 |
-3.49% |
1,793,896 |
81% |
$3.5B |
- |
112% |
-15% |
+51.3% |
$21.0M | 888.2K shares - No Change
No Alerts/News
|
|
|
| VRTX |
$78.43 |
-1.04 |
-1.31% |
1,446,078 |
42% |
$17.1B |
- |
104% |
-10% |
+45.2% |
$92.0M | 1.7M shares - decrease of 358.6K shares
No Alerts/News
|
|
|
|
|
Discuss BB Biotech's portfolio
|
|
|
|
| |

|
| |
|
| |

|
| |
Roche, Reloaded BMY JNJ MRK GILD RHHBY
Linked by Investopedia Stock Analysis ( track newsfeed | ignore newsfeed ) - May 21, 03:00PM from (www.investopedia.com) Roche has one of the best long-term growth profiles in the Big Pharma space
Flag
Post a comment
$307,000-a-year Vertex Drug: Billions in Sales? VRTX
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - May 20, 12:50PM from (ycharts.com) Here is a question that is likely to plague the pharmaceutical industry and patient advocacy groups for some time to come:
Flag
Post a comment
Mid-Morning Market Update: Housing Starts Plummet, Initial Jobless Claims Rise AMD CSCO HALO DRYS ONTY
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 16, 10:51AM from (www.benzinga.com) Following the market opening Wednesday, the Dow traded down 0.12 percent to 15,257.00, while the NASDAQ rose 0.15 percent
Flag
Post a comment
Top New Biotech Ideas from PropThink CELG REGN CBST VPHM ONXX AVEO MAKO
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 16, 07:30AM from (247wallst.com) The world of biotech investing is always a difficult one. Often a binary event, such as a Food and Drug Administration (FDA)
Flag
Post a comment
Deutsche Bank Firm on Biotech Stocks to Buy AMGN CELG REGN BIIB VRTX GILD ALXN ONXX DB
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 15, 08:10AM from (247wallst.com) Biotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and
Flag
Post a comment
BioMarin to Present at the UBS Global Healthcare Conference BMRN
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 14, 09:13AM from (globenewswire.com) SAN RAFAEL, Calif., May 14, 2013 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Dan
Flag
Post a comment
Mid-Day Market Update: US Stocks Fall on Monday, Gold Down AA INTC ELN GNVC THRX EOX RCON TSLA SCTY
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 13, 01:18PM from (www.benzinga.com) Midway through trading Monday, the Dow fell 0.20 percent to 15,089. The NASDAQ rose 0.22 percent to 3,444.14, while the S&P rose 0.04 percent to 1,634.41.
Flag
Post a comment
Wall Street Lower in Early Trader S ELN DISH KCG THRX GSK
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - May 13, 09:16AM from (www.nytimes.com) Indexes retreated from record highs in the previous session, though an unexpected rise in retail sales data for April helped
Flag
Post a comment
Theravance and Elan Enter Into a $1.0 Billion Royalty Participation Agreement ELN THRX
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 13, 02:02AM from (www.businesswire.com) Theravance, Inc. (NASDAQ: THRX) and Elan Corporation, plc (NYSE: ELN) today announced that they have entered into a royalty
Flag
Post a comment
S&P Highlights Biotech ETFs ABT JNJ AMGN CELG BIIB VRTX GILD NPSP IBB BBH PJP XBI
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 10, 07:39AM from (www.benzinga.com) Bolstered by an accommodating Food & Drug Administration and promising recent clinical results for drugs aimed at
Flag
Post a comment
Medivation Reports First Quarter Financial Results and Provides Corporate Update MDVN
Linked by marketwire ( track newsfeed | ignore newsfeed ) - May 09, 04:10PM from (www2.marketwire.com) Medivation, Inc. (NASDAQ: MDVN) today provided a corporate update and reported its financial results for the first quarter
Flag
Post a comment
|
|